PharmaCyte Biotech
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has PharmaCyte Biotech's balance sheet done over the years? Its assets were worth $59,903,883 last year, which is less than in the previous period. 34% of PharmaCyte Biotech’s total assets is currently financed by debt. Its liabilities reached the amount of $20,389,264, which means an increase by 3376% compared compared to last year.
Debt to Assets
| 2015 | 7948468 | 2.01M | 25.32% |
|---|---|---|---|
| 2016 | 7160325 | 637.63K | 8.91% |
| 2017 | 8667495 | 580.24K | 6.69% |
| 2018 | 6412857 | 644.16K | 10.04% |
| 2019 | 5782396 | 742.85K | 12.85% |
| 2020 | 6166638 | 1.07M | 17.48% |
| 2021 | 7404229 | 724.77K | 9.79% |
| 2022 | 90624136 | 704.37K | 0.78% |
| 2023 | 73276925 | 586.58K | 0.8% |
| 2024 | 59903883 | 20.38M | 34.04% |
PMCB Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 50.17M | 68.03M | 85.40M | 2.20M | 894.86K | 515.25K | 1.05M | 3.46M | 1.92M | 2.69M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other current assets | 259.8K | 215.36K | 94.17K | 73.13K | 142.78K | 138.15K | 224.06K | 148.54K | 110.02K | 1.46M |
Total current assets | 50.43M | 68.14M | 85.49M | 2.27M | 1.03M | 653.40K | 1.28M | 3.53M | 2.03M | 2.81M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 1.54M | 3.54M | 3.54M | 3.54M | 3.54M | 3.54M | 3.54M | 3.54M | 3.54M | 3.54M |
Long term investments | 0 | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M |
Other non-current assets | 7.91M | 7.68K | 7.68K | 7.37K | 7.37K | 7.37K | 7.37K | 7.37K | 7.85K | 7.85K |
Total non-current assets | 9.46M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M |
Total assets | 59.90M | 73.27M | 90.62M | 7.40M | 6.16M | 5.78M | 6.41M | 8.66M | 7.16M | 7.94M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | -50.80K | 0 | 0 | 0 | 0 | 0 | 0 |
Short term debt | 0 | 0 | 0 | 50.80K | 28.91K | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 7.42M | 586.58K | 704.37K | 724.77K | 1.03M | 742.85K | 644.16K | 580.24K | 637.63K | 2.01M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 46.28K | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 12.96M | 0 | 205.36K | 0 | -7 | 121.88K | 0 | 0 | 0 | 0 |
Total non-current liabilities | 12.96M | 0 | 205.36K | 0 | 46.28K | 121.88K | 0 | 0 | 0 | 0 |
Total liabilities | 20.38M | 586.58K | 704.37K | 724.77K | 1.07M | 742.85K | 644.16K | 580.24K | 637.63K | 2.01M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |